Progress towards optimal trial end-points in rheumatoid arthritis

BioDrugs

Volumn 7, Issue 1, 1997, Pages 40-50

  Boers, Maarten ^a,d   Tugwell, Peter ^b   Brooks, Peter M ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISABILITY; DISEASE ACTIVITY; HEALTH STATUS; HUMAN; MEASUREMENT; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS;

EID: 0030746597     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199707010-00006     Document Type: Article

References (60)

1. Pincus T, Callahan LF. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity, and mortality of rheumatoid arthritis. Scand J Rheumatol 1989; 79 Suppl.: 67-95
2. Kirwan JR. A theoretical framework for process, outcome and prognosis in rheumatoid arthritis. J Rheumatol 1992; 19: 333-6
3. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire. J Rheumatol 1982; 9: 789-93
4. Meenan RF, Gutman PM, Mason JH. Measuring health status in rheumatoid arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23: 146-52
5. Meenan RF, Mason JH, Anderson JJ, et al. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales health status questionnaire. Arthritis Rheum 1992; 25: 1-10
6. Ware JE, Donald-Sherbourne C. The MOS 36 item Short Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 6: 473-83
7. Hunt SM, McKenna SP, McEwen J, et al. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 1981; 15A: 221-9
8. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9
9. Tugwell P, Boers M, for the OMERACT committee. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: conclusion. J Rheumatol 1993; 20: 590
10. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991; 18: 1298-306
11. Anderson JJ, Felson DT, Meenan RF, et al. Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 1989; 32: 1093-9
12. Gøtzsche PC. Sensitivity of effects variables in rheumatoid arthritis: a meta-analysis of 130 placebo-controlled NSAID trials. J Clin Epidemiol 1990; 43: 1313-8
13. Van de Heide A, Jacobs WGJ, Dinant HJ, et al. The impact of endpoint measures in rheumatoid arthritis clinical trials. Semin Arthritis Rheum 1992; 21: 287-94
14. Tugwell P, Boers M, for the OMERACT committee. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 555-6
15. Wall PD. Introduction. In: Wall PD, Melzack R, editors. Textbook of pain. 2nd ed. London: Churchill Livingstone, 1989
16. Van der Heijde DMFM, van Riel PLCM, van Rijswijk MH, et al. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988; 17: 284-92
17. Bellamy N. Musculoskeletal clinical metrology. London: Kluwer, 1993: 65-76
18. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 729-40
19. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15
20. Bombardier C, Raboud J and the Auranofin Cooperating Group. A comparison of health related quality of life measures for rheumatoid arthritis clinical research. Controlled Clin Trials 1991; 12: S243-56
21. Hazes JMW, Hayton R, Silman AJ. A reevaluation of the symptom of morning stiffness. J Rheumatol 1993; 20: 1138-42
22. Meenan RF, Pincus T. The status of patient status measures. J Rheumatol 1987; 14: 411-4
23. Bellamy N. Musculoskeletal clinical metrology. London: Kluwer, 1993: 117-9
24. Spiegel TM, Spiegel JS, Paulus HE. The joint alignment and motion scale: a simple measure of joint deformity in patients with rheumatoid arthritis. J Rheumatol 1987; 14: 887-92
25. Parker JW, Harrell PB, Alarcon GS. The value of the joint alignment and motion scale in rheumatoid arthritis. J Rheumatol 1988; 15: 1212-5
26. Bosi Ferraz M, Atra E, De Oliviera LM. What is the purpose of the joint alignment and motion scale [letter]? J Rheumatol 1989; 16: 853-4
27. Bosi Ferraz M, de Oliviera LM, Araujo PMP, et al. EPM-ROM Scale: an evaluative instrument to be used in rheumatoid arthritis clinical trials. Clin Exp Rheumatol 1990; 8: 491-4
28. Vliet Vlieland TPM, Van den Ende CHM, Breedveld FC, et al. Evaluation of joint mobility in rheumatoid arthritis clinical trials: the EPM-range of motion scale. J Rheumatol 1993; 20: 2010-4
29. Hawley DJ, Wolfe F. Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short term clinical trials and observational studies versus long term observational studies. Arthritis Health Care Res 1992; 5: 130-6
30. Tugwell P, Bombardier C, Buchanan WW, et al. The MACTAR patient preference disability questionnaire: an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987; 14: 446-51
31. Guillemin F, Briançon S, Pourel J. Functional disability in rheumatoid arthritis: two different models in early and established disease. J Rheumatol 1992; 19: 366-9
32. Cooperating clinics of the American Rheumatism Association. A seven day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965; 8: 302-34
33. Ritchie DM, Boyle JA, McInnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 147: 393-406
34. Fuchs HA, Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994; 37: 470-5
35. Lansbury J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis: theoretic and clinical considerations. Arthritis Rheum 1958; 1: 505-22
36. Thompson PW, Kirwan JR, Currey HLF. A comparison of the ability of 28 articular indices to detect an induced flare of joint inflammation in rheumatoid arthritis. Br J Rheumatol 1988; 27: 375-80
37. Klinkhoff AV, Bellamy N, Bombardier C et al. An experiment in reducing inter-observer variability in the examination for joint tenderness. J Rheumatol 1988; 15: 492-4
38. Prevoo MLL, van Riel PLCM, van't Hof MA, et al. Validity and reliability of joint indices: a longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 1993; 32: 589-94
39. Van Riel PLCM. Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis. Br J Rheumatol 1992; 31: 793-4
40. American College of Rheumatology Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Reduced joint counts in rheumatoid arthritis clinical trials. Arthritis Rheum 1994; 37: 463-4
41. Scott DL, Panayi GS, Van Riel PLCM, et al. Disease activity in rheumatoid arthritis: preliminary report. Clin Exp Rheumatol 1992; 10: 521-35
42. Van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al. The acute phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of disease. Br J Rheumatol 1993; 32 Suppl. 3: 9-13
43. Boers M, Tugwell P. The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 568-74
44. Fries JF, Bloch DA, Sharp JT, et al. Assessment of radiologic progression in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum 1986; 29: 1-9
45. Edmunds JP, Scott DL, Furst DE, et al. Antirheumatic drugs: a proposed new classification. Arthritis Rheum 1993; 36: 336-9
46. Iannuzzi L, Dawson N, Zein N, et al. Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 1983; 309: 1023-8
47. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977; 18: 481-91
48. Sharp JT. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 1989; 32: 221-9
49. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow up study of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26-34
50. Wassenberg S, Herborn G, Kreutzburg S, et al. Larsen's method is as precise as Sharp's method in detecting change in long term observation of radiographs in RA. Arthritis Rheum 1995; 38 Suppl.: S329
51. Van der Heijde DMFM, Van Leeuwen MA, Van Riel PLCM et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26-34
52. Boers M. The validity of radiography as outcome measure in rheumatoid arthritis. J Rheumatol 1995; 22: 1783-6
53. Tugwell P, Boers M. OMERACT conference on outcome measures in clinical trials: introduction. J Rheumatol 1993; 20: 528-9
54. Boers M, Tugwell P, for the OMERACT committee. Conference on outcome measures in rheumatoid arthritis clinical trials, Maastricht, The Netherlands, April 29-May 3, 1992. J Rheumatol 1993; 20: 525-91
55. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994; 21 Suppl. 41: 86-9
56. Tugwell P, Boers M, Brooks PM, OMERACT committee. OMERACT II: conference on outcome measures in rheumatoid arthritis clinical trials. J Rheumatol 1995; 22: 980-1433
57. Edmonds J, editor. Proceedings of the 5th Joint World Health Organization and International League of Associations for Rheumatology Task Force meeting on Rheumatic Diseases. J Rheumatol 1994; 21 Suppl. 41: 1-86
58. Felson DT, Anderson J, Boers M, et al. American College of Rheumatology preliminary criteria for improvement in rheumatoid arthritis patients. Arthritis Rheum 1995; 38: 727-35
59. Van Gestel AM, Van't Hof MA, Van Rijswijk MH, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organisation/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39: 34-40
60. Van der Heijde DMFM, Van't Hof MA, Van Riel PLCM, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-20